ENZON PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enzon Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Enzon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2022 was $0.000.
  • Enzon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $0.000.
  • Enzon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $0.000.
  • Enzon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $0.000.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-02-16
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-02-23
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-02-19
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2018-03-21
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2017-03-24
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2016-03-21
2014 $0 -$4K -100% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-05
2013 $4K -$37K -90.2% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-05
2012 $41K Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.